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Objective: The objective of the study was to evaluate the phytoconstituents and in vitro thrombolytic and antiproteinase activities of aqueous extracts 
of leaf, stem, and root of Wedelia trilobata.
Methods: In vitro thrombolytic activity of aqueous extracts of different parts of W. trilobata against thrombus. In vitro antiproteinase activity of 
aqueous extracts of different parts of W. trilobata.
Results: Phytochemical screening of aqueous extracts of leaf, stem, and flower of W. trilobata showed various bioactive constituents such as 
carbohydrates, protein, phenols, tannins, saponins, alkaloids, terpenoids, and quinines in all three parts of aqueous extracts. The maximum fibrinolysis 
(blood clot lysis) was observed in leaf extracts when compared to stem and extracts of flower W. trilobata. The highest degree of proteinase activity 
was showed in stem of W. trilobata.
Conclusions: Hence, the aqueous extracts of a different part of W. trilobata possess many phytocompounds may be responsible for thrombolytic and 
antiproteinase activities. In further, to isolate the particular phytocompounds from this plant may be substantiate an effective drug in pharmacologic 
aspect as thrombolytic and anti-inflammatory therapy.
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INTRODUCTION
Herbal plants have always been considered as a healthy resource of 
life for all people. Therapeutically properties of medical plants are very 
useful remedies in various diseases, and the advantage of these medicinal 
plants is being 100% natural. Nowadays people are being bombard 
with thousands of unhealthy products, the level of sensibility in front of 
diseases is very high and the use of medicinal plants can characterize the 
best solution [1]. A medicinal plant is one or more bioactive constituents 
that can be used for beneficial resolution and also used as a precursor for 
the production of drugs [2]. Herbal products are extensively perceived as 
safe because they are “natural” [3] having less or no side effects.
Thrombosis is the important pathophysiological process that underlies 
the acute coronary disorders such as pulmonary emboli, deep vein 
thrombosis, strokes, and heart attacks; which are the main causes 
of morbidity and mortality in developed countries [4]. This disease 
is characterized by the development of a blood clot (thrombus) in 
the circulatory system of the body due to the failure of homeostasis 
which leads to vascular blockage and while recovering causes fatal 
significances, myocardial or cerebral infarction, as well as death [5]. 
Therefore, anticoagulation treatment is the basis of management, and 
the proper choice of thrombolytic drugs to decrease platelet aggregation. 
Intravenous heparin, the first line of the treatment for cerebral venous 
sinus thrombosis, is used in the anticoagulation therapy because it is 
safe, effective and feasible. The thrombolytic agents are anistreplase, 
streptokinase, alteplase, tissue plasminogen activator, and urokinase [3].
Inflammation is a local response of living mammalian tissues to 
injury. It is a body defense reaction to eliminate or limit the spread of 
injurious agents. There are various components to an inflammatory 
reaction that can contribute to the associated symptoms and tissue 
injury and pain. Even though most of the synthetic anti-inflammatory 
drugs are accessible in the market, due to their well-known side effects, 
harmfulness and manufacture cost are higher. In many inflammatory 
disorders, there is excessive activation of phagocytes, production of 
O2−,OH- radicals as well as non free radicals species (H2O2) [6]. Drugs 
from plant origin are relied on by 80% of the world’s population. 
In India, the use of herbal drugs is an important component of the 
traditional system of medicine.
Wedelia trilobata is a flowering plant of sunflower family, Asteraceae. 
A tropical perennial medicinal herb, with deeply lobed fleshy leaves and 
flowers are orange - yellow. W. trilobata is a medicinal plant used to 
treat hepatitis infections, to clear the placenta after birth and is used 
for menstrual pain and unspecified female complaints [7]. W. trilobata 
is various biological activities, such as antidiabetic, antibacterial, 
antitumor, hepatoprotective, and central nervous system depressant 
properties [8]. Hence, the present study aimed to evaluate the 
phytochemical, in vitro thrombolytic and anti-inflammatory potential 
of aqueous extracts of three different parts (leaf, stem, and flower) of 
W. trilobata (L.).
METHODS
Collection of plant materials
Plant of W. trilobata was collected from Mayiladuthurai, Nagapattinam 
(District), Tamil Nadu, India, during November 2016. The plant was 
identified and authenticated by Dr. S. John Britto, Director, Rapinat 
Herbarium and Centre for Molecular Systematics, Department of 
Botany, St. Joseph’s College, Tiruchirappalli, Tamil Nadu, India. The 
leaf, stem, and flowers of plant materials were separated and washed 
thoroughly in tap water followed by distilled water. The parts of plant 
were shade dried under the room temperature for 7 days after plant 
materials were uniformly grinded well using a mechanical grinder. The 
powder materials were stored in air tight container.
Preparation of extracts
To one part of powder plant materials and three parts of distilled water 
was added separately and boiling the contents thoroughly to reduce the 
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original volume. After boiling the contents were filter through muslin 
clothes and then the filtrate was evaporated to boiling water bath. 
A paste form of extracts was store separated in airtight containers at 
4°C, which was subjected to various analyses.
Qualitative method of phytochemical analysis
The leaf, stem, and flower of W. trilobata extract alkaloids, carbohydrates, 
glycosides, protein, steroids, tannins, phenols, flavonoids coumarins, 
saponins, quinone, terpenoids, phlobatannins, and anthraquinones 
were analyzed by standard procedure [2].
In vitro thrombolytic activity
In vitro thrombolytic activity was carried out by Prasad et al. [9]. Venous 
blood samples (3 ml) were drawn from healthy human volunteer. 200 μl 
of blood was transferred to each of previously weighed Eppendorf tubes 
for each subject. In the first series, the transferred 200 μl allowed to form 
clots at 37°C for 45 minutes. After clot formation, serum was completely 
removed and each tube having clot was again weighed to determine the 
clot weight (clot weight=weight of clot containing tube−weight of the 
tube alone). To each Eppendorf containing pre-weighed clot, 200-1000 μl 
of different concentration of plant extracts, or 100 μl distilled water as a 
negative control were added. All the tubes were then incubated at 37°C 
for 90 minutes and observed for clot lysis. After incubation, fluid released 
was removed, and tubes were again weighed to observe the difference 
in weight after clot stabilization. The obtained difference in weight was 
expressed as a percentage of lysed clot. In the another Eppendorf tubes 
second series of experiments, simultaneous addition of 200 µl of blood 
and 1000 µl of heparin, incubated at 37°C for 90 minutes.
% of clot lysis=









W1=Empty weight of Eppendorf tube,
W2=Weight of Eppendorf tube+clot,
W3=Weight of clot release after addition of plant extract.
In vitro antiproteinase activity
The antiproteinase activity was performed according to Oyedepo and 
Femurewa [10] with minor modification. The reaction mixture (2 ml) 
was containing 0.06 mg trypsin, 20 mM Tris HCl buffer (pH 7.4) and 
1 ml test sample of different concentrations (200-1000 μg/ml). The 
mixture was incubated for 20 minutes. After incubation 2 ml of 70% 
perchloric acid was added to arrest the reaction. Cloudy suspension was 
centrifuged, and the absorbance of the supernatant was read at 210 nm 
against buffer as blank. The experiment was performed as triplicate. The 
percentage inhibition of proteinase inhibitory activity was calculated.
Percentage inhibition =








Qualitative analysis of phytocompounds
Phytochemical screening of aqueous extracts of different part of 
W. trilobata (L.) results was shown in Table 1. In this study, the higher 
concentration of alkaloids, carbohydrates, proteins, tannins, phenols, 
saponins, quinines and terpenoids observed in leaf, stem, and flower of 
W. trilobata. Whereas of glycosides and phlobatannins were absent in 
all the three parts of plant. Flavonoids, coumarins, and anthraquinones 
were present only in aqueous extract of leaf of W. trilobata.
In vitro thrombolytic activity
In this study, aqueous extract of leaf, stem, and flower of W. trilobata 
was screened against thrombus, and the results were shown in 
Tables 2-4 and Fig. 1. 1 ml of heparin as a positive control (1000 IU/ml) 
added to clots and consequent incubation for 90 minutes at 37°C, it 
showed 70.00% lysis of clot. On the distilled water was treated as 
negative control which revealed as a negligible percentage of lysis of 
clot (6.25%). The aqueous extract of leaf of W. trilobata exhibited a 
higher degree of thrombolytic activity at all the concentration. The 
minimum of clot lysis was seen in the aqueous extract of stem of 
W. trilobata.
In vitro antiproteinase activity
The aqueous extracts of W. trilobata showed significant antiproteinase 
activity at different concentration (200-1000 µg/ml), and the results 
were showed in Table 5 and Fig. 2. The maximum inhibition of 
proteinase activity (48±4.34) was revealed in the aqueous extracts 
Table 1: Screening of bioactive phytocompound in aqueous 
extract of W. trilobata
Name of the 
phytocompounds
Aqueous extracts
 Leaf Stem Flower
Alkaloids +++ +++ +++
Carbohydrates +++ +++ +++
Glycosides - - -
Proteins + + +
Steroids + + +++
Tannins +++ ++ +++
Phenols +++ +++ +++
Flavonoids + - -
Coumarins + - -
Saponins +++ +++ +++
Quinines +++ ++ +++
Terpenoids ++ ++ +++
Phlobatannins - - -
Anthraquinones ++ + +++
Fig. 1: In vitro thrombolytic activity of aqueous extracts of leaf, 
stem, and flower of Wedelia trilobata (L.). Values are expressed as 
mean±standard error (n=3)
Fig. 2: In vitro antiproteinase activity of aqueous extracts of Wedelia 
trilobata (L.). Values are expressed as mean±standard error (n=3)
+++ (highly); ++ (moderate); + (mild); - (absent); + (present). 
W. trilobata: Wedelia trilobata
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of W. trilobata flower at the concentration of 1000 µg/ml. Which was 
compared with leaf and stem of W. trilobata and diclofenac sodium 
(1 mg/ml). The minimum antiproteinase activity (12±3.88) exhibited 
in stem extract of W. trilobata at the concentration 200 µg/ml. In 
this study, the membrane stabilization was improved on increasing 
concentration of plant extracts.
DISCUSSION
The phytochemicals access is very significant aspects in 
pharmacognostic evaluation of medicinal plants [11]. The researcher 
reported phytocompounds possess antioxidant, antimicrobial, and 
anti-inflammatory properties and use in the therapy of various 
infection diseases, etc. [12]. Plants are an important source for the 
development of potential new chemotherapeutic drugs and its use as 
a health treatment in folklore medicine [13]. The bioactive of plant 
extracts is qualified to phytochemical constituents alkaloids isolated 
and characterized from Alstonia rupestris with cytotoxic, antibacterial, 
and antifungal activities [14] also antioxidant properties [15]. These 
secondary metabolites are possess various pharmacological activities 
are hypoglycemic, antidiabetic, antioxidant, antimicrobial, anti-
inflammatory, anticarcinogenic, antimalarial, anticholinergic, and 
antileprosy [16]. Nisreen and Anil [17] reported the phytochemical 
analyses of flower extracts of W. trilobata. Similarly, in this study, the 
various pharmacological active phytoconstituents observed in aqueous 
extracts of leaf, stem, and flower of W. trilobata.
Table 2: In vitro thrombolytic activity of aqueous extract of W. trilobata leaf
Concentration of 
plant extracts  
(µg/ml)
Weight of empty 
tube (A) g
Weight of tube 
with clot (B) g
Weight of 
clot (C) (B‑A) g
Weight of tube 




% of clot 
lysis
Average 
% of clot 
lysis
Blank 1.030 1.140 0.110 1.130 0.010 9.09
200 1.010 1.200 0.190 1.160 0.040 21.05
400 1.030 1.120 0.090 1.100 0.020 22.22
600 1.020 1.150 0.130 1.110 0.040 30.76 35.208
800 1.030 1.200 0.170 1.130 0.070 41.17
1000 1.020 1.210 0.190 1.100 0.110 57.89
Heparin (1 m1/m1) 1.040 1.180 0.140 1.090 0.090 64.28
W. trilobata: Wedelia trilobata
Table 3: In vitro thrombolytic activity of aqueous extract of W. trilobata stem
Concentration of 
plant extracts (µg/ml)
Weight of empty 
tube (A) g
Weight of tube 
with clot (B) g
Weight of 
clot (C) (B‑A) g
Weight of tube 




% of clot 
lysis
Average 
% of clot 
lysis
Blank 1.010 1.170 0.160 1.160 0.010 6.25
200 1.000 1.160 0.160 1.140 0.020 12.50
400 1.030 1.090 0.060 1.080 0.010 16.66
600 1.030 1.140 0.110 1.120 0.020 18.18 24.560
800 1.010 1.090 0.080 1.070 0.020 25.00
1000 1.010 1.100 0.090 1.070 0.030 33.33
Heparin (1 m1/ml) 1.020 1.120 0.100 1.060 0.060 60.00
W. trilobata: Wedelia trilobata
Table 4: In vitro thrombolytic activity of aqueous extract of W. trilobata flower
Concentration of plant 
extracts (µg/ml)
Weight of empty 
tube (A) g
Weight of tube 
with clot (B) g
Weight of 
clot (C) (B‑C) g
Weight of tube 




% of clot 
lysis
Average 
% of clot 
lysis
Blank 1.020 1.120 0.100 1.130 0.010 8.33
200 1.020 1.130 0.110 1.100 0.030 27.27
400 1.010 1.180 0.170 1.120 0.060 35.29
600 1.030 1.140 0.110 1.100 0.040 36.36 36.392
800 1.010 1.170 0.160 1.120 0.060 37.50
1000 1.030 1.130 0.100 1.090 0.040 40.00
Heparin (1 ml/ml) 1.020 1.120 0.100 1.050 0.070 70.00
W. trilobata: Wedelia trilobata
Table 5: In vitro antiproteinase activity of aqueous extracts of W. trilobata
Concentration of plant extracts (µg/ml) % antiproteinase activity Diclofenac sodium (1 mg/ml)
Leaf Stem Flower
200 16±4.33 12±3.88 24±4.12 -
400 20±3.72 16±4.33 26±3.33 -
600 26±3.33 22±4.02 36±4.33 -
800 36±3.77 27±4.21 44±3.90 -
1000 42±4.92 36±4.21 48±4.34 53±4.34
Values are expressed as mean±SE (n=3). SE: Standard error, W. trilobata: Wedelia trilobata
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Atherothrombotic diseases like myocardial or cerebral infarction occur 
due to the development of thrombus that causes interruption in the 
passage of vessels [18]. At present, various thrombolytic agents in 
practice are being used to dissolve the clots that have already formed in 
the blood vessels; but these drugs have certain restrictions and can lead 
to possible fatal consequences in some cases. A number of researchers 
reported the plant and natural products possess thrombolytic activity 
(anticoagulant and antiplatelet) [19].
A natural fibrinolytic agent is plasmin, lyses clot by disrupting the 
fibrinogen and fibrin contained in a clot. Again, cell surface bound 
plasminogen is easily activated to plasmin, which could lead to 
fibrinolysis [20]. Streptokinase forms a complex with plasminogen, 
which is converted plasminogen to plasmin [21]. Scientists have 
discovered several thrombolytic drugs from various sources [9]. 
Those thrombolytic drugs more site specific and effective [22]. 
Unfortunately, side effects related to these drugs such as bleeding and 
embolism [23]. In past two decades toward the investigation, finding, 
design, and improvement of natural products with anticoagulant [24], 
antithrombotic [25], and thrombolytic activity of the plants [26]. 
Few plant extracts and their products having fibrinolytic activity are 
identified, which includes Flammulina velutipes [27], and Ganoderma 
lucidum [28], ginger (Zingiber officinale) [29], and garlic (Allium 
sativum) [30].
Proteinases have been associated in arthritic reactions. Neutrophils 
are known to be a source of proteinase, which carries in their 
lysosomal granules many serine proteinases. It was earlier reported 
that leukocytes proteinase play a central role in the improvement 
of tissue damage through in inflammatory reactions and important 
level of defense was provided by proteinase inhibitors [31]. Plant 
phenolic and flavonoids compounds possess potent anti-inflammatory 
activity [32,33]. Tannins, saponins, and terpenoids were observed plant 
extracts may possess potent and anti-inflammatory properties [34-36]. 
In this study, the maximum antiproteinase activity showed in aqueous 
extracts of W. trilobata flower, it may be due to the presence of flavonoids 
and related polyphenols compounds as contributed significant to 
antiproteinase activities against proteinase action [37].
CONCLUSION
A medicinal plant is contain bioactive substances that can be used for 
a therapeutic purpose which are precursors for the synthesis of useful 
drugs. In this study, in vitro thrombolytic and antiproteinase activities 
of different parts of W. trilobata. Phytochemical analysis of aqueous 
extracts of leaf, stem, and flower of W. trilobata showed carbohydrates, 
protein, phenols, tannins, saponins, alkaloids, terpenoids, and quinines 
in all three parts of aqueous extracts. The maximum dissolution of 
blood clot (fibrinolysis) was observed in leaf extracts W. trilobata. The 
highest degree of proteinase inhibitory activity was showed in flower of 
W. trilobata. Hence, the aqueous extracts of a different part of W. trilobata 
revealed that significant thrombolytic and antiproteinase activities. In 
further, to isolate the phytocompounds, from this plant for synthesis of 
the effective drug in thrombolytic and anti-inflammatory therapy.
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